证券之星消息，12月4日，深港通医疗（983035）指数报收于4472.99点，跌0.53%，成交59.38亿元，换 手率0.69%。当日该指数成份股中，上涨的有18家，微创机器人-B以5.48%的涨幅领涨，下跌的有38家， 一脉阳光以7.29%的跌幅领跌。 深港通医疗（983035）指数十大成份股详情如下： | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 200.00 | 0.25% | | 2424.88 | 一 医药生物 | | sz300015 | 爰尔眼科 | 11.62% | 11.23 | -1.06% | | 1047.24 | 医药生物 | | sz300003 | 乐普医疗 | 4.85% | 15.66 | -0.89% | | 288.68 | 医药生物 | | sz300896 | 爱美客 | 4.80% | 140.41 | -2.29% | S | 424.87 | 美 ...

资金流向方面，深港通医疗(港币)（983036）指数成份股当日主力资金净流出合计3.3亿元，游资资金净 流入合计979.64万元，散户资金净流入合计3.2亿元。成份股资金流向详情见下表： 证券之星消息，12月4日，深港通医疗(港币)（983036）指数报收于4382.53点，跌0.57%，成交65.4亿 元，换手率0.69%。当日该指数成份股中，上涨的有18家，微创机器人-B以5.48%的涨幅领涨，下跌的有 38家，一脉阳光以7.29%的跌幅领跌。 深港通医疗(港币)（983036）指数十大成份股详情如下： | 深港通医疗(港币)指数 十大成份股 | | --- | | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 200.00 | 0.25% | 2424.88 | 医药生物 | | sz300015 | 爰尔眼科 | 11.62% | 11.23 | -1.06% | 1047.24 | 医药生物 | | sz3 ...

Core Viewpoint - The financial performance of Kangtong Medical shows a significant decline in revenue and net profit, indicating potential challenges for the company in the near future [2]. Group 1: Financial Performance - As of November 28, 2025, Kangtong Medical reported a revenue of 344 million yuan, a year-on-year decrease of 30.06% [2]. - The company recorded a net profit of -10.21 million yuan, reflecting a year-on-year decrease of 150.92% [2]. - Cumulative cash dividends since the A-share listing amount to 48.9973 million yuan [3]. Group 2: Shareholder and Market Activity - As of December 3, 2025, the number of shareholders for Kangtong Medical is 7,481, a decrease of 5.24% from the previous period [2]. - The average number of circulating shares per shareholder is 8,426, which has increased by 5.53% compared to the last period [2]. - On December 3, 2025, the stock price of Kangtong Medical fell by 0.72%, with a trading volume of 19.146 million yuan [1]. Group 3: Financing and Margin Trading - On December 3, 2025, Kangtong Medical had a financing buy-in of 543,400 yuan, with a net financing buy of -148,120 yuan [1]. - The total financing and margin trading balance for Kangtong Medical is 29.0609 million yuan, with the financing balance accounting for 1.90% of the circulating market value [1]. - The company’s margin trading balance is at a high level, with a margin balance of 2,197 yuan and a margin stock quantity of 100 shares [1]. Group 4: Business Overview - Kangtong Medical, established on January 13, 1998, is located in Chengdu, Sichuan Province, and was listed on July 25, 2023 [1]. - The company's main business involves providing medical institutions with overall solutions centered on medical gas systems and clean operating rooms [1]. - The revenue composition includes: 55.69% from clean medical equipment and systems, 37.30% from medical gas equipment and systems, 4.06% from medical equipment and other product sales, 2.81% from operation and maintenance services, and 0.14% from other sources [1].

Core Points - The Shenzhen-Hong Kong Medical Index (983035) closed at 4495.04 points, down 0.66%, with a trading volume of 6.607 billion yuan and a turnover rate of 0.76% [1] - Among the index constituents, 11 stocks rose while 46 fell, with Xianjian Technology leading the gainers at 5.38% and Health Road leading the decliners at 5.3% [1] Index Constituents - The top ten constituents of the Shenzhen-Hong Kong Medical Index include: - Mindray Medical (14.56% weight) at 199.50 yuan, down 0.56% [1] - Aier Eye Hospital (11.62% weight) at 11.35 yuan, down 1.30% [1] - Lejin Medical (4.85% weight) at 15.80 yuan, up 0.38% [1] - Aimeike (4.80% weight) at 143.70 yuan, down 0.94% [1] - Yuyue Medical (4.66% weight) at 36.03 yuan, up 0.59% [1] - Yingke Medical (3.64% weight) at 43.22 yuan, up 1.93% [1] - Furuishi (3.59% weight) at 66.98 yuan, down 0.56% [1] - Meinian Health (3.58% weight) at 5.13 yuan, down 1.54% [1] - Sinopharm (3.35% weight) at 18.52 yuan, down 0.59% [1] - Ping An Good Doctor (2.63% weight) at 13.20 yuan, down 1.43% [1] Capital Flow - The index constituents experienced a net outflow of 301 million yuan from institutional investors, while retail investors saw a net inflow of 174 million yuan [3] - Notable capital flows include: - Meihua Medical with a net inflow of 21.18 million yuan from institutional investors [3] - Kefu Medical with a net inflow of 14.75 million yuan from institutional investors [3] - Yuyue Medical with a net inflow of 6.16 million yuan from institutional investors [3] Recent Adjustments - The Shenzhen-Hong Kong Medical Index has undergone adjustments, with one new stock added in the last ten days [3]

证券之星消息，12月3日，深港通医疗(港币)（983036）指数报收于4406.01点，跌0.65%，成交72.8亿 元，换手率0.76%。当日该指数成份股中，上涨的有11家，先健科技以5.38%的涨幅领涨，下跌的有46 家，健康之路以5.3%的跌幅领跌。 深港通医疗(港币)（983036）指数十大成份股详情如下： | 证券代码 | 股票简称 | 权重 | 最新价 | 涨跌幅 | 总市值(亿元) | 所属行业 | | --- | --- | --- | --- | --- | --- | --- | | sz300760 | 迈瑞医疗 | 14.56% | 199.50 | -0.56% | 2418.82 | 医药生物 | | sz300015 | 爰尔眼科 | 11.62% | 11.35 | -1.30% | 1058.43 | 医药生物 | | sz300003 | 乐晋医疗 | 4.85% | 15.80 | 0.38% | 291.26 | 医药生物 | | sz300896 | 爱美客 | 4.80% | 143.70 | -0.94% | 434.82 | 美容护理 | | sz002223 ...

Group 1 - The core viewpoint of the news is that 港通医疗 (Kangtong Medical) is experiencing a decline in financial performance, with significant decreases in both revenue and net profit year-on-year [2] - As of December 2, 港通医疗's stock price decreased by 0.23%, with a trading volume of 22.5 million yuan, and a net financing purchase of 518,800 yuan [1] - The company's financing balance is 30.54 million yuan, which is 1.98% of its market capitalization, indicating a low level compared to the past year [1] Group 2 - 港通医疗's revenue for the period from January to September 2025 was 344 million yuan, representing a year-on-year decrease of 30.06% [2] - The company reported a net profit attributable to shareholders of -10.21 million yuan, a significant decline of 150.92% compared to the previous year [2] - The company has distributed a total of 48.99 million yuan in dividends since its A-share listing [3] Group 3 - As of November 28, 港通医疗 had 7,481 shareholders, a decrease of 5.24% from the previous period, while the average number of circulating shares per person increased by 5.53% to 8,426 shares [2] - The top ten circulating shareholders include 诺安多策略混合A (Noah Multi-Strategy Mixed A), which holds 725,100 shares as a new shareholder [3] - The company's main business involves providing medical institutions with overall solutions centered on medical gas systems and clean operating rooms, with revenue contributions of 55.69% from clean equipment and systems, 37.30% from medical gas equipment and systems, and 4.06% from other medical equipment sales [1]

Core Points - The Shenzhen-Hong Kong Stock Connect Medical Index (HKD) closed at 4433.77 points, down 0.69%, with a trading volume of 6.716 billion HKD and a turnover rate of 0.73% [1] - Among the index constituents, 18 stocks rose while 39 stocks fell, with Global Medical leading the gainers at 3.66% and Health Road leading the decliners at 6.35% [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Stock Connect Medical Index include: - Mindray Medical (14.56% weight, latest price 200.62, market cap 243.24 billion) [1] - Yier Eye Hospital (11.62% weight, latest price 11.50, market cap 107.24 billion) [1] - Lejin Medical (4.85% weight, latest price 15.74, market cap 29.01 billion) [1] - Aimeike (4.80% weight, latest price 145.06, market cap 43.89 billion) [1] - Yuyue Medical (4.66% weight, latest price 35.82, market cap 35.91 billion) [1] - Yingke Medical (3.64% weight, latest price 42.40, market cap 27.78 billion) [1] - Furuide (3.59% weight, latest price 67.36, market cap 17.85 billion) [1] - Meinian Health (3.58% weight, latest price 5.21, market cap 20.39 billion) [1] - Sinopharm (3.35% weight, latest price 18.63, market cap 58.14 billion) [1] - Ping An Good Doctor (2.63% weight, latest price 13.39, market cap 28.93 billion) [1] Capital Flow Analysis - The net outflow of main funds from the index constituents totaled 83.77 million HKD, while retail investors saw a net inflow of 61.08 million HKD [1] - Specific stock capital flows include: - Mindray Medical: main fund net inflow of 37.11 million, retail net outflow of 4.23 million [2] - Yuyue Medical: main fund net inflow of 3.70 million, retail net inflow of 4.71 million [2] - Over the past 10 days, one stock was newly added to the index [2]

Core Viewpoint - The Shenzhen-Hong Kong Medical Index (983035) closed at 4523.97 points, down 0.72%, with a trading volume of 6.097 billion yuan and a turnover rate of 0.73% on December 2 [1]. Group 1: Index Performance - Among the index constituents, 18 stocks rose while 39 stocks fell, with Global Medical leading the gainers at a 3.66% increase and Health Road leading the decliners at a 6.35% decrease [1]. - The top ten constituents of the Shenzhen-Hong Kong Medical Index include major companies such as Mindray Medical (14.56% weight, latest price 200.62 yuan, -0.50% change) and Aier Eye Hospital (11.62% weight, latest price 11.50 yuan, -0.60% change) [1]. Group 2: Capital Flow - The net outflow of main funds from the index constituents totaled 83.77 million yuan, while retail investors saw a net inflow of 61.08 million yuan [3]. - Specific stock capital flows indicate that Mindray Medical experienced a net inflow of 37.11 million yuan from main funds, while it faced a net outflow of 32.88 million yuan from speculative funds [3]. - The index constituents underwent an adjustment in the last 10 days, with one new stock added [3].

来源：新浪证券-红岸工作室 融资方面，港通医疗当日融资买入183.27万元。当前融资余额3002.12万元，占流通市值的1.94%，融资 余额低于近一年10%分位水平，处于低位。 融券方面，港通医疗12月1日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量100.00股，融券余额2218.00元，超过近一年90%分位水平，处于高位。 资料显示，四川港通医疗设备集团股份有限公司位于四川省成都市简阳市凯力威工业大道南段356号， 成立日期1998年1月13日，上市日期2023年7月25日，公司主营业务涉及为医疗机构提供以医用气体系统 及医院洁净手术部为核心的医疗专业工程整体方案。主营业务收入构成为：医用洁净装备及系统 55.69%，医用气体装备及系统37.30%，医疗设备及其他产品销售4.06%，运维服务2.81%，其他(补 充)0.14%。 截至11月20日，港通医疗股东户数7895.00，较上期减少2.64%；人均流通股7984股，较上期增加 2.71%。2025年1月-9月，港通医疗实现营业收入3.44亿元，同比减少30.06%；归母净利润-1020.84万 元，同比 ...

投资者提问：你好，作为贵公司的中小股投资者，截止11月28日的股东人数是多少人，谢谢！ 港通医疗回复：尊敬的投资者，您好！公司截至2025年11月28日股东总户数为7481户，感谢您的关注。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 证券之星消息，港通医疗(301515)12月01日在投资者关系平台上答复投资者关心的问题。 ...